A 2,7-dichlorofluorescein derivative to monitor microcalcifications.
Mol Syst Des Eng
; 7(11): 1415-1421, 2022 Nov 01.
Article
em En
| MEDLINE
| ID: mdl-37927331
ABSTRACT
Herein, we report the crystal structure of 2,7-dichlorofluorescein methyl ester (DCF-ME) and its fluorescence response to hydroxyapatite binding. The reported fluorophore is very selective for staining the bone matrix and provides turn-on fluorescence upon hydroxyapatite binding. The reported fluorophore can readily pass the cell membrane of the C2C12 cell line, and it is non-toxic for the cell line. The reported fluorophore DCF-ME may find applications in monitoring bone remodeling and microcalcification as an early diagnosis tool for breast cancer and age-related macular degeneration.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Mol Syst Des Eng
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Alemanha